Franklin Genomic Advancements ETF

Franklin Genomic Advancements ETF is an ETF issued by Franklin Resources, Inc. on Feb 25 2020. The main focus of this ETF, which is in the "Equity" asset class, is determined as "Theme". As of today, the price of HELX ETF according to its net asset value is premiumed at 0.12%. While the total value of the fund shows $-740,000 decrease compared to the previous month, its price is traded daily at a decrease of -1.83%. The annual dividend yield of HELX ETF is 0.00%, whereas its main asset area is Global. HELX ETF, whose 24-hour total volume is $890, has experienced a $0 cash outflow in the last month. In addition, Franklin Genomic Advancements ETF's net asset value total return is 0.00%.